A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Arsenne MekinianLin-Pierre ZhaoSylvie ChevretKristell DesseauxLaurent PascalThibaut ComontAlexandre MariaPierre PeterlinLouis TerriouMaud D'Aveni PineyMarie-Pierre GourinNorbert VeyOdile Beyne RauzyVincent GrobostHoly BezanaharySophie Dimicoli-SalazarAnne BanosStefan WickenhauserBenoit De RenzisEric DurotShanti Natarajan-AméLaurent VoillatFatiha ChermatKarine LemaireVincent JachietChantal HimberlinSylvain ThépotJose Miguel Torregrosa DiazLaurent FrenzelEmmanuel GyanGuillaume DenisPierre HirschOlivier KosmiderLionel AdesOlivier FainPierre FenauxPublished in: Leukemia (2022)